Cargando…
Transducin (β)-like 1 X-linked receptor 1 correlates with clinical prognosis and clinicopathological characteristics in human solid carcinomas
Transducin (β)-like 1 X-linked receptor 1(TBL1XR1) has been reported to be overexpressed in various human cancers, as well as contributing to carcinogenesis and progression. This synthetic analysis was performed to assess whether TBL1XR1 protein could act as a potential prognostic molecular marker f...
Autores principales: | Liu, Fangteng, Gao, Hui, Zhao, Yang, Zhu, Zhengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617451/ https://www.ncbi.nlm.nih.gov/pubmed/28977891 http://dx.doi.org/10.18632/oncotarget.18650 |
Ejemplares similares
-
Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway
por: Zhou, Q, et al.
Publicado: (2017) -
The role of transducin β-like 1 X-linked receptor 1 (TBL1XR1) in thyroid hormone metabolism and action in mice
por: Hu, Yalan, et al.
Publicado: (2023) -
Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in Nasopharyngeal Carcinoma via activation of NF-κB pathway
por: Chen, Shu-Peng, et al.
Publicado: (2014) -
Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling
por: Li, Xinghua, et al.
Publicado: (2014) -
Clinicopathologic and Prognostic Significance of Transducin-Like Enhancer of Split 1 Protein Expression in Invasive Breast Cancer
por: Lee, Ji-Hye, et al.
Publicado: (2017)